Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody
- PMID: 6268690
- DOI: 10.1007/BF03350444
Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody
Abstract
The usefulness of solubilized TSH-receptor for measuring TSH and TSH-displacing antibodies (TDA) in a radioligand receptor assay (RRA) was investigated. Crude thyroid membranes were solubilized with Triton X-100. A soluble protein fraction was isolated by DEAE-Sephadex A-50 ion-exchange chromatography. The binding of 125I-TSH to the solubilized fraction was studied. It was maximal after 45 min at 37 C, whereas at 4 C a similar binding was observed after at least 17 h. The binding was inhibited by Ca2+ and Mg2+ with concentrations higher than 1 mM and by NaCl in the concentration range 17-150 mM. No inhibition of binding was found with normal serum up to 100 microliter. In contrast, 1.5 microliter of a Graves' disease serum showed significant inhibition. Using the system to measure TSH in serum, as low as 10 microunits TSH could be estimated. Compared to an RRA using thyroid membrane fractions, the sensitivity for TSH in serum as well as for TDA is increased at least tenfold in our system.
Similar articles
-
Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.J Clin Endocrinol Metab. 1981 Apr;52(4):665-70. doi: 10.1210/jcem-52-4-665. J Clin Endocrinol Metab. 1981. PMID: 6110672
-
Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.J Clin Invest. 1984 Sep;74(3):1090-7. doi: 10.1172/JCI111476. J Clin Invest. 1984. PMID: 6088581 Free PMC article.
-
Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes.Endocrinol Jpn. 1982 Apr;29(2):227-31. doi: 10.1507/endocrj1954.29.227. Endocrinol Jpn. 1982. PMID: 6127209
-
TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. doi: 10.1055/s-2004-817930. Exp Clin Endocrinol Diabetes. 2004. PMID: 15127319 Review.
-
Autoantibodies to the thyrotropin receptor.Endocr Rev. 1988 Feb;9(1):106-21. doi: 10.1210/edrv-9-1-106. Endocr Rev. 1988. PMID: 3286231 Review.
Cited by
-
TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.J Endocrinol Invest. 1983 Oct;6(5):375-8. doi: 10.1007/BF03347619. J Endocrinol Invest. 1983. PMID: 6141201
-
Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.J Endocrinol Invest. 1983 Apr;6(2):135-8. doi: 10.1007/BF03350586. J Endocrinol Invest. 1983. PMID: 6134766
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous